Helixa Lifesciences Private Limited, a active private limited company, was established on 30 October 2017 in Hyderabad, Telangana, India. Engaging in biotechnology within the hospital and medical care sector, it holds CIN: U74999TG2017PTC120315. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sravani Doddala (Director), Viplav Kumar Valluri Lakshmisathyanarayana (Director), Doddala Sankara Mahadev (Director). Past directors included Sravani Doddala, Venu Kathineedi Sudheer. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 202,10-2-298/86, Pritinadita Residency, Shanti Nagar, Hyderabad, Telangana, 500028.
U74999TG2017PTC120315
120315
30 October 2017
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Helixa Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sravani Doddala | Director | 07 Apr 2020 | Current |
| Viplav Kumar Valluri Lakshmisathyanarayana | Director | 30 Oct 2017 | Current |
| Doddala Sankara Mahadev | Director | 30 Oct 2017 | Current |
| Venu Kathineedi Sudheer | Director | 19 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Helixa Lifesciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 57.33% increase. The company also saw a substantial fall in profitability, with a 75.18% decrease in profit. The company's net worth Soared by an impressive increase of 19.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Helixa Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Helixa Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Helixa Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Helixa Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Helixa Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Helixa Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was recorded as a recent event.
Progress on Sravani Doddala was appointed as a Director was appointed as a Director on 07 Apr 2020 & has been associated with this company since 5 years 9 months . was documented.
The activity Venu Kathineedi Sudheer was appointed as a Director was appointed as a Director on 19 Feb 2018 & has been associated with this company since 7 years 10 months . was completed.
Viplav Kumar Valluri Lakshmisathyanarayana was appointed as a Director was appointed as a Director on 30 Oct 2017 & has been associated with this company since 8 years 2 months . was recorded as a recent event.
Doddala Sankara Mahadev was appointed as a Director was appointed as a Director on 30 Oct 2017 & has been associated with this company since 8 years 2 months . was recorded as a recent event.
The CIN of Helixa Lifesciences Private Limited is U74999TG2017PTC120315.
Helixa Lifesciences Private Limited is headquartered at 202,10-2-298/86, Pritinadita Residency, Shanti Nagar, Hyderabad, Telangana, 500028.
Helixa Lifesciences Private Limited was incorporated on 30 October 2017.
The current directors of Helixa Lifesciences Private Limited are
The primary industry of Helixa Lifesciences Private Limited is Hospital And Medical Care.
Helixa Lifesciences Private Limited is unlisted.
The authorized capital of Helixa Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Helixa Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX